GBA1 and Parkinson disease: Moreover, ABX (99) treatment resulted in increased brain GCase activity in a transgenic mouse model expressing the heterozygous L444P mutation in the murine GBA gene, a PD model of healthy carrier of GD (GBA-PD model) [101].